Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination

Journal of Clinical Microbiology

Volumn 46, Issue 5, 2008, Pages 1602-1605

  Grisaru, Dan ^a,b   Avidor, Boaz ^a   Niv, Jacob ^a   Marmor, Silvia ^a   Almog, Benjamin ^a   Leibowitz, Cecilia ^a   Graidy, Merav ^a   Giladi, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOASSAY; BIOPSY; CANCER INVASION; COLPOSCOPY; DIAGNOSTIC KIT; ELECTROSURGERY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN TISSUE; INCIDENCE; INFECTION RISK; ISRAEL; JEW; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS EPITHELIUM; VIRUS INFECTION; WART VIRUS; WART VIRUS 52;

ADULT; COLPOSCOPY; FEMALE; GENOTYPE; HUMANS; ISRAEL; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; PREVALENCE; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS;

EID: 43249118468     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02483-07     Document Type: Article

References (18)

1. Carozzi, F., S. Bisanzi, C. Sani, M. Zappa, S. Cecchini, S. Ciatto, and M. Confortini. 2007. Agreement between the Amplicor HPV test and the Hybrid Capture 2 assay in the detection of high-risk human papillomavirus and biopsy-confirmed high-grade cervical disease. J. Clin. Microbiol. 45:364-369.
2. Clifford, G. M., S. Gallus, R. Herrero, N. Munoz, P. J. Snijders, S. Vaccarella, P. T. Anh, C. Ferreccio, N. T. Hieu, E. Matos, M. Molano, R. Rajkumar, G. Ronco, S. de Sanjose, H. R. Shin, S. Sukvirach, J. O. Thomas, S. Tunsakul, C. J. Meijer, and S. Franceschi. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991.
3. Clifford, G. M., R. K. Rana, S. Franceschi, J. S. Smith, G. Gough, and J. M. Pimenta. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 14:1157.
4. Clifford, G. M., J. S. Smith, T. Aguado, and S. Franceschi. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89:101.
5. Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63.
6. Didelot-Rousseau, M. N., N. Nagot, V. Costes-Martineau, X. Valles, A. Ouedraogo, I. Konate, H. A. Weiss, P. Van de Perre, P. Mayaud, and M. Segondy. 2006. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br. J. Cancer 95:355.
7. Dunne, E. F., E. R. Unger, M. Sternberg, G. McQuillan, D. C. Swan, S. S. Patel, and L. E. Markowitz. 2007. Prevalence of HPV infection among females in the United States. JAMA 297:813.
8. Glezerman, M., B. Piura, and V. Insler. 1989. Cervical cancer in Jewish women. Am. J. Obstet. Gynecol. 161:1186.
9. Menczer, J., Y. Fintsi, S. Arbel-Alon, L. Tell, E. Friedman, A. Jackman, and L. Sherman. 2000. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Eur. J. Gynaecol. Oncol. 21:30.
10. Monsonego, J., J. M. Bohbot, G. Pollini, C. Krawec, C. Vincent, I. Merignargues, F. Haroun, P. Sednaoui, L. Monfort, R. Dachez, and K. Syrjanen. 2005. Performance of the Roche Amplicor human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal Pap smear. Gynecol. Oncol. 99:160.
11. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518.
12. Poljak, M., K. Fujs, K. Seme, B. J. Kocjan, and E. Vrtacnik-Bokal. 2005. Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples. Acta Dermatovenerol. Alp. Panonica Adriat 14:147.
13. Sadan, O., E. Schejter, S. Ginath, R. Bachar, M. Boaz, J. Menczer, and M. Glezerman. 2004. Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women. Arch. Gynecol. Obstet. 269:188.
14. Sandri, M. T., P. Lentati, E. Benini, P. Dell'Orto, L. Zorzino, F. M. Carozzi, P. Maisonneuve, R. Passerini, M. Salvatici, C. Casadio, S. Boveri, and M. Sideri. 2006. Comparison of the Digene HC2 assay and the Roche Amplicor human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J. Clin. Microbiol. 44:2141.
15. van Ham, M. A., J. M. Bakkers, G. K. Harbers, W. G. Quint, L. F. Massuger, and W. J. Melchers. 2005. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche Amplicor HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J. Clin. Microbiol. 43:2662.
16. Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, J. Paavonen, O. E. Iversen, S. E. Olsson, J. Hoye, M. Steinwall, G. Riis-Johannessen, A. Andersson-Ellstrom, K. Elfgren, G. Krogh, M. Lehtinen, C. Malm, G. M. Tamms, K. Giacoletti, L. Lupinacci, R. Railkar, F. J. Taddeo, J. Bryan, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2006 High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br. J. Cancer 95:1459.
17. Vizcaino, A. P., V. Moreno, F. X. Bosch, N. Munoz, X. M. Barros-Dios, J. Borras, and D. M. Parkin. 2000. International trends in incidence of cervical cancer. II. Squamous-cell carcinoma. Int. J. Cancer 86:429.
18. Zuna, R. E., R. A. Allen, W. E. Moore, R. Mattu, and S. T. Dunn. 2004. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod. Pathol. 17:1314.